Department of Exercise Science, Bond University, Queensland, Australia.
Am J Med. 2011 Nov;124(11):1073-80.e2. doi: 10.1016/j.amjmed.2011.04.026.
BACKGROUND: As late provision of specialist care, before starting dialysis therapy, is believed to be associated with increased morbidity and mortality, a systematic review was undertaken to evaluate clinical outcomes relating to early versus late referral of patients to nephrology services. METHODS: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and EMBASE were searched up until September 2008 for studies of early versus late nephrology referral in adult (>18 years) patients with chronic kidney disease. Early referral was defined by the time period at which patients were referred to a nephrologist. FINDINGS: No randomized controlled trials were found. Twenty-seven longitudinal cohort studies were included in the final review, providing data on 17,646 participants; 11,734 were referred early and 5912 (33%) referred late. Comparative mortality was higher in patients referred to a specialist late versus those referred early. Odds ratios (OR) for mortality reductions in patients referred early were evident at 3 months (OR 0.51; 95% confidence interval [CI], 0.44-0.59) and remained at 5 years (OR 0.45; 95% CI, 0.38-0.53), both P <.00001. Initial hospitalization was 8.8 days shorter with early referral (95% CI, -10.7 to -7.0 days; P <.00001). Differences in mortality and hospitalization data between the 2 groups were not explained by differences in prevalence of diabetes mellitus, previous coronary artery disease, blood pressure control, serum phosphate, and serum albumin. However, early referral was associated with better preparation and placement of dialysis access. CONCLUSION: Our analyses show reduced mortality and hospitalization, better uptake of peritoneal dialysis, and earlier placement of arteriovenous fistula for hemodialysis with early nephrology referral.
背景:由于在开始透析治疗前晚期提供专科护理被认为与发病率和死亡率增加有关,因此进行了系统评价,以评估与将患者转至肾病科的早期与晚期相关的临床结果。
方法:截至 2008 年 9 月,对 Cochrane 对照试验中央注册库(CENTRAL)、MEDLINE 和 EMBASE 进行了检索,以查找慢性肾脏病成年(>18 岁)患者早期与晚期转至肾病科的研究。早期转诊是通过患者转至肾病医生的时间来定义的。
发现:没有随机对照试验。最终综述纳入了 27 项纵向队列研究,共纳入 17646 名参与者;11734 名患者被早期转诊,5912 名(33%)被晚期转诊。与早期转至专科的患者相比,晚期转诊的患者死亡率更高。早期转诊患者的死亡率降低的比值比(OR)在 3 个月时明显(OR 0.51;95%置信区间 [CI],0.44-0.59),并持续到 5 年(OR 0.45;95% CI,0.38-0.53),均 P<.00001。早期转诊时的初始住院时间缩短了 8.8 天(95% CI,-10.7 至-7.0 天;P<.00001)。两组间死亡率和住院数据的差异不能用糖尿病、先前的冠心病、血压控制、血清磷酸盐和血清白蛋白的差异来解释。然而,早期转诊与更好的透析通路准备和放置相关。
结论:我们的分析显示,早期转至肾病科可降低死亡率和住院率,提高腹膜透析的接受度,并更早地进行血液透析的动静脉瘘置管。
Cochrane Database Syst Rev. 2014-6-18
Cochrane Database Syst Rev. 2024-6-20
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2017-6-28
Cochrane Database Syst Rev. 2012-5-16
Nephrology (Carlton). 2025-7
Kidney Med. 2025-2-15
Kidney360. 2025-2-1